Company profile for Vivani Medical

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Second Sight’s mission is to develop neurostimulation technologies to enhance the lives of blind individuals, while supporting our current users.The recognized global leader in neuromodulation devices to treat blindness, the company leverages its 20 years of technology innovation to develop devices to treat the broadest population of sight-impaired individuals. Inspired by personal connections with a retinitis pigmentosa dia...
Second Sight’s mission is to develop neurostimulation technologies to enhance the lives of blind individuals, while supporting our current users.The recognized global leader in neuromodulation devices to treat blindness, the company leverages its 20 years of technology innovation to develop devices to treat the broadest population of sight-impaired individuals. Inspired by personal connections with a retinitis pigmentosa diagnosis, Second Sight has researched, designed and created the world’s first FDA and CE Mark approved device for providing artificial vision in people with late-stage RP.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
13170 Telfair Avenue Sylmar, CA 91342
Telephone
Telephone
+1 (818) 833-5000
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/13/3187219/0/en/Vivani-Medical-Provides-Business-Update-and-Reports-Third-Quarter-2025-Financial-Results.html

GLOBENEWSWIRE
13 Nov 2025

https://www.globenewswire.com/news-release/2025/10/28/3175941/0/en/Vivani-Medical-Inc-Announces-Closing-of-Common-Stock-Offering.html

GLOBENEWSWIRE
28 Oct 2025

https://www.globenewswire.com/news-release/2025/10/26/3174279/0/en/Vivani-Medical-Inc-Announces-Pricing-of-Common-Stock-Offering.html

GLOBENEWSWIRE
26 Oct 2025

https://www.globenewswire.com/news-release/2025/10/22/3171115/0/en/Vivani-Medical-to-Present-at-the-ThinkEquity-Conference-on-October-30-2025.html

GLOBENEWSWIRE
22 Oct 2025

https://www.globenewswire.com/news-release/2025/10/03/3160943/0/en/Vivani-Medical-Withdraws-Record-Date-for-Cortigent-Neuromodulation-Subsidiary-Spin-Off.html

GLOBENEWSWIRE
03 Oct 2025

https://www.globenewswire.com/news-release/2025/09/17/3151620/0/en/Vivani-Medical-Announces-Record-Date-for-Spin-off-of-Cortigent-Neuromodulation-Subsidiary-to-Shareholders.html

GLOBENEWSWIRE
17 Sep 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty